Objective To analyze the research hotspots and development trends in the field of pharmacy popularization in China,and to provide references and feasible suggestions for the practice of popular science in pharmacy and related research.Methods The CNKI,WanFang Data and VIP databases were searched to collect relevant references on popular science in pharmacy studies from January 2014 to February 2024,and the the authors,institutions and the literature's keywords of relevant references were analyzed using bibliometric methods and CiteSpace visualization software.Results 332 papers were included in the research,with an overall increasing trend in the number of publications.The cooperation networks of authors and research institutions were relatively scattered,research institutions were mainly concentrated in medical universities and tertiary hospitals.The main hotspot keywords were rational medication use,questionnaire survey,clinical pharmacist,COVID-19,pharmacist,influencing factors,WeChat platform,medication safety,children,medication consultation,medication risk,Chinese patent medicines,pharmaceutical management,knowledge-attitude-practice,compliance,et al.At present,there is still a high level of concern and emergence intensity of medication risk,knowledge-attitude-practice,medication therapy management and"Internet+".Conclusion The study of popularization of pharmacy science in China is in a stage of rapid development,but the enthusiasm and professional capabilities of pharmaceutical practitioners still need to be improved.In the future,it is necessary to actively promote deep exchanges and cooperations of scholars and institutions,explore the deep integration paths of popular science in pharmacy with information technology and new medical service models,and enhance the public's awareness and ability for safe medication through precise and efficient popularization strategies,thereby contributing to the in-depth implementation of the Healthy China strategy.

The Health-Related Quality of Life (HRQoL) pertains to patients' subjective contentment concerning their physical, psychological, and social well-being throughout disease treatments. Predominantly employed HRQoL metrics in spinal metastases comprise the 36-item Short-Form Health Survey (SF-36), EuroQoL Five Dimensions Questionnaire (EQ-5D), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), and the Functional Assessment of Cancer Therapy-General (FACT-G). In clinical applications, due to their broad application and diverse disease types, combined with the lack of specificity in the scale content and the prolixity of their questionnaires, these tools often fail to capture the nuanced experiences of patients, thereby compromising the reliability and validity of the results. The Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ), developed by the Spine Oncology Study Group, offers a tailored metric for spinal metastases, encapsulating both specificity and inclusivity. Its proven robust reliability and validity make it invaluable for decision-making and therapeutic efficacy appraisals. The Patient-Reported Outcome Measurement Information System (PROMIS), a novel metric suitable across many medical disciplines, facilitates cross-sector data acquisition, substantially augmenting the precision, sensitivity, and credibilityof assessments, and is pivotal in clinical investigations and interventions. As it continually evolves, PROMIS consistently outperforms traditional metrics in evaluative capacities, exhibiting impressive and consistent proficiency in prognostications, preoperative assessments, and therapeutic outcome evaluations within the spinal metastasis domain. Presently, Chinese research on the HRQoL of spinal metastasis patients remains scant, and choosing an apt, precise, and dependable metric holds significant clinical relevance. Drawing upon extant scholarly publications, this review concluded the current global HRQoL tools for spinal metastases, aiming to furnish insights for the clinical management and research pertaining to spinal metastases.

OBJECTIVE: To investigate the clinical outcomes of patients with aneurysmal subarachnoid hemorrhage (aSAH) after surgeries in Yunnan Province. METHODS: We retrospectively analyzed the demographic features, vascular risk factors, severity at admission, and aneurysm locations in 85 patients with aSAH receiving surgical interventions in Yunnan Province. All the patients were treated by aneurysm clipping or coiling and followed up for clinical outcomes and recovery of daily activities evaluated by modified Rankin Scale (mRS) and Activities of Daily Living (ADL) scale, respectively. RESULTS: Thirty-four of the patients (40.0%) underwent aneurysm clipping and 51 (60.0%) underwent aneurysm coiling. During a median follow- up period of 66.23 months (IOR, 12.03 months), 84.7% of the patients had low mRS scores, and 78.8% lived independently. The WFNS grade at admission was significantly correlated with the follow-up mRS scores (95%: 1.48-19.09, =0.011) and ADL (95%: 2.55-28.77, < 0.001). Multivariate analysis showed that age (95%: 1.02-1.23, =0.017; 95%: 1.00-1.15, =0.038) and a high WFNS grade at admission (95%: 2.19-141.48, =0.007; 95%: 2.84-82.61, =0.002) were independent predictors of both mRS and ADL scores at follow-up. There was no significant difference in clinical outcomes or the length of hospital stay between the two treatment strategies ( > 0.05), but the cost of hospitalization was significantly higher in coiling group than in the clipping group ( < 0.001). CONCLUSIONS Both aging and a high WFNS grade at admission are associated with a poor prognosis of aSAH, for which aneurysm clipping and coiling have similar long- term outcomes, but for patients with a high WFNS score, aneurysm clipping is favored over coiling in terms of health economics.

OBJECTIVETo observe depot medroxyprogesterone acetate (DMPA) and testosterone undecanoate (TU) injected at 8-week intervals for the suppression of spermatogenesis in healthy Chinese men.

METHODSAfter screening, 30 healthy volunteers were enrolled and randomly assigned to 3 dosage-groups (n = 10/group): 1000 mg TU (Group A), 1000 mg TU plus 150 mg DMPA (Group B), 1000 mg TU plus 300 mg DMPA (Group C). All dosages were given as intramuscular injections at 8-week intervals. The study consisted of an 8-week control (baseline) period, a 24-week treatment period and a 24-week recovery period.

RESULTSConsistent azoospermia or severe oligozoospermia was achieved and maintained in all the volunteers during the treatment period, except 2 in the mere TU group who experienced a "rebound" in sperm concentrations. An 8-week regimen of TU plus DMPA at both tested combination dosages effectively suppressed spermatogenesis to azoospermia. All volunteers tolerated the injections; no serious adverse effects were reported.

CONCLUSIONThe lower combined dosage is recommended for further testing in an expanded clinical trial or contraceptive efficacy study.

Adult ; Androgens ; pharmacology ; China ; Gonadotropin-Releasing Hormone ; biosynthesis ; Humans ; Hypothalamo-Hypophyseal System ; metabolism ; Male ; Medroxyprogesterone Acetate ; pharmacology ; Prospective Studies ; Sperm Count ; Spermatogenesis ; drug effects ; Testosterone ; analogs & derivatives ; pharmacology

OBJECTIVETo investigate the effect of Trx-LHRH, a new GnRH crasis protein, on antibody production and male reproductive function.

METHODSTrx-LHRH produced in vitro with a new crasis gene which crasised Trx gene and GnRH gene together, was used as vaccine, and hydroalaminum base as adjuvant, in adult SD rats. After 5 weeks of the first treatment, the same dosage was used again to enhance the effect of vaccine. Antibody level was measured by ELISA, and androgen level by RIA.

RESULTSTrx-LHRH induced successfully the polycolonal antibody at the level of 1 :1 280 approximately 2 560 after 4 weeks of the first treatment, and 1 : 2 000 after 6 weeks of the enhanced treatment. Testosterone level was reduced significantly (P < 0.01) by ELISA, but there was reasonable variation among individuals. Sperm count was also reduced by Trx-LHRH treatment.

CONCLUSIONTrx-LHRH can be used as effective vaccine to induce antibody production, and at the same time, restrain the function of hypothatamas-pituitary-testis axis in vivo.

Animals ; Antibodies ; blood ; Gonadotropin-Releasing Hormone ; immunology ; Male ; Rats ; Rats, Sprague-Dawley ; Recombinant Fusion Proteins ; immunology ; Sperm Count ; Testosterone ; blood ; Thioredoxins ; immunology ; Vaccines, Synthetic ; immunology

Objective:To compare the assessments on hyperkinetic syndrome of ADHD between teachers and psychiatrists,in order to determine their roles in our later study about ADHD.Method:Pediatric psychiatrists from Guangzhou psychiatric hospital and pre-occupational or experienced teachers from Fangcun elementary school(30 in each group)rated the presence and degree of hyperactive-disruptive behaviors in a standardized videotape,showing one 7-year-old boy who participated in individual and group activities.The results were compared between each group.Results:There was no significant difference on most of the assessments between psychiatrists and experienced teachers.The assessments of pre-occupational teachers had significant differences to the results of the above two groups.Conclusion:The assessments of experienced teachers may be used as very important information on the early diagnosis and the assessments of effectiveness of medical intervention for ADHD children.